229 related articles for article (PubMed ID: 33515703)
1. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma.
Arzuaga-Mendez J; Lopez-Santillan M; Garcia-Ruiz JC; Lopez-Lopez E; Martin-Guerrero I
Crit Rev Oncol Hematol; 2021 Mar; 159():103247. PubMed ID: 33515703
[TBL] [Abstract][Full Text] [Related]
2. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.
Roehle A; Hoefig KP; Repsilber D; Thorns C; Ziepert M; Wesche KO; Thiere M; Loeffler M; Klapper W; Pfreundschuh M; Matolcsy A; Bernd HW; Reiniger L; Merz H; Feller AC
Br J Haematol; 2008 Sep; 142(5):732-44. PubMed ID: 18537969
[TBL] [Abstract][Full Text] [Related]
4. The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.
Fassina A; Marino F; Siri M; Zambello R; Ventura L; Fassan M; Simonato F; Cappellesso R
Lab Invest; 2012 Nov; 92(11):1574-82. PubMed ID: 22964854
[TBL] [Abstract][Full Text] [Related]
5.
Musilova K; Devan J; Cerna K; Seda V; Pavlasova G; Sharma S; Oppelt J; Pytlik R; Prochazka V; Prouzova Z; Trbusek M; Zlamalikova L; Liskova K; Kruzova L; Jarosova M; Mareckova A; Kornauth C; Simonitsch-Klupp I; Schiefer AI; Merkel O; Mocikova H; Burda P; Machova Polakova K; Kren L; Mayer J; Zent CS; Trneny M; Evans AG; Janikova A; Mraz M
Blood; 2018 Nov; 132(22):2389-2400. PubMed ID: 30213873
[TBL] [Abstract][Full Text] [Related]
6. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
Lawrie CH; Chi J; Taylor S; Tramonti D; Ballabio E; Palazzo S; Saunders NJ; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS
J Cell Mol Med; 2009 Jul; 13(7):1248-60. PubMed ID: 19413891
[TBL] [Abstract][Full Text] [Related]
7. MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages.
Lou X; Fu J; Zhao X; Zhuansun X; Rong C; Sun M; Niu H; Wu L; Zhang Y; An L; Guo L; Wan S; Wang S
J Exp Clin Cancer Res; 2020 Nov; 39(1):237. PubMed ID: 33168041
[TBL] [Abstract][Full Text] [Related]
8. Transformed follicular lymphoma.
Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
[TBL] [Abstract][Full Text] [Related]
9. Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma.
Larrea E; Fernandez-Mercado M; Guerra-Assunção JA; Wang J; Goicoechea I; Gaafar A; Ceberio I; Lobo C; Okosun J; Enright AJ; Fitzgibbon J; Lawrie CH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233721
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA
Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
12. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].
Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M
Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients.
Hu M; Wang X; Liu N; Ding K; Zhang G; Liu X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34109978
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.
Pon JR; Marra MA
Blood; 2016 Jan; 127(2):181-6. PubMed ID: 26447189
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling of Chinese follicular lymphoma by microarray: A preliminary study.
Pan Y; Guo Y; Luo Y; Li H; Xu Y
Int Immunopharmacol; 2016 Oct; 39():41-47. PubMed ID: 27409728
[TBL] [Abstract][Full Text] [Related]
16. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.
Culpin RE; Proctor SJ; Angus B; Crosier S; Anderson JJ; Mainou-Fowler T
Int J Oncol; 2010 Aug; 37(2):367-76. PubMed ID: 20596664
[TBL] [Abstract][Full Text] [Related]
17. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas.
Veryaskina YA; Titov SE; Kovynev IB; Pospelova TI; Fyodorova SS; Shebunyaeva YY; Sumenkova DV; Zhimulev IF
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894763
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10
Azoulay D; Cohen HI; Dementiev E; Eshel E; Akria L; Shaoul E; Horowitz N
Cytometry B Clin Cytom; 2020 Sep; 98(5):449-453. PubMed ID: 31816181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
